Lee D. Flowers - 08 Dec 2023 Form 4 Insider Report for HCW Biologics Inc. (HCWB)

Role
SVP of Business Development
Signature
/s/ Nicole Valdivieso, as Attorney-in-Fact for Lee D. Flowers
Issuer symbol
HCWB
Transactions as of
08 Dec 2023
Net transactions value
+$1,050
Form type
4
Filing time
11 Dec 2023, 16:56:11 UTC
Previous filing
09 Jun 2023
Next filing
22 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCWB Common Stock Options Exercise $1,050 +7,501 +6.7% $0.1400* 118,809 08 Dec 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCWB Stock Option (Right to Buy) Options Exercise $0 -7,501 -100% $0.000000* 0 08 Dec 2023 Common Stock 7,501 $0.1400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 20% of the total shares subject to the stock option grant vested on September 16, 2020; 20% of the total shares subject to the stock option grant vested on September 16, 2021; 25% of the total shares subject to the stock option grant vested on September 16, 2022; and 35% of the total shares subject to the stock option grant vested on September 16, 2023.